Farallon Capital Management’s Celyad Oncology SA American Depositary Shares CYAD Stock Holding History

Farallon Capital Management’s Portfolio CYAD Stock Details CYAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-30,000	Closed	-$1.56M	–	100
2015 Q2	$1.56M	Buy	+30,000	New	+$1.61M	0.02%	90

Other funds holding CYAD

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Zurich Cantonal Bank Zurich, Switzerland $46B AUM 27.59% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Farallon Capital Management's CYAD Position: Q3 2015 in Review

Farallon Capital Management sold out of Celyad Oncology SA American Depositary Shares (CYAD) in Q3 2015, closing a stake of 30,000 shares — an estimated $1.56M sold.

Farallon Capital Management first reported a position in CYAD in Q2 2015 and held it in 1 quarter. The position peaked at $1.56M in Q2 2015. 10 funds tracked by Wall St. Rank hold CYAD as of Q3 2015.

Farallon Capital Management reported no remaining Celyad Oncology SA American Depositary Shares position as of Q3 2015 after selling out during the quarter.
Farallon Capital Management sold 30,000 Celyad Oncology SA American Depositary Shares shares in Q3 2015, an estimated $1.56M.
Farallon Capital Management first reported a position in Celyad Oncology SA American Depositary Shares in Q2 2015 and held it in 1 quarter.
Farallon Capital Management's Celyad Oncology SA American Depositary Shares position peaked at $1.56M in Q2 2015.
10 funds tracked by Wall St. Rank held Celyad Oncology SA American Depositary Shares as of Q3 2015.

Based on Farallon Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.